For roughly 25 years, and sources have been used in the treatment of various malignant
diseases such as prostate cancer. Various new sources have been marketed and produced …

brachytherapy sources are being used for interstitial implants in tumor sites such as the
prostate. Recently, the ADVANTAGE™ Model IAI‐125, source became commercially …

Four new brachytherapy sources, IRA1‐, IRA2‐, IRA3‐, and IRA4‐, have been developed at
Agricultural, Medical, and Industrial Research School and are designed for permanent …

Objective: Recently, a new catheter-based 32P brachytherapy source has been developed
(College of Chemistry, Sichuan University) for use in high-dose-rate afterloader. This study …

The American Association of Physicists in Medicine recommends that the reference dose‐
rate distribution, used for treatment planning for low‐energy photon brachytherapy sources …

This work provides full dosimetric data for a new high‐strength source currently launched by
Varian Oncology Systems for use in their high dose rate remote afterloading systems. The …

Dosimetric measurements were performed to characterize a new source that is a variant
design of an existing source, designated as MED3631‐A/S, and that has application in …

and brachytherapy sources are being used for interstitial implants in tumor sites such as the
prostate. Recently, a double‐wall source has been introduced, which has a design different …

Low‐energy gamma emitting isotopes encapsulated for permanent implant are in routine
use in the treatment of prostate cancer. New source designs require full dosimetric analysis …

Monte Carlo calculations and TLD measurements have been performed for the purpose of
characterizing dosimetric properties of new commercially available brachytherapy sources …